ANIX News and Press, Anixa Biosciences Inc. From 04/17/23

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine PR Newswire Immune responses were observed at all dose levels SAN JOSE, Calif. , April 17, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: AN...

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting PR Newswire SAN JOSE, Calif. , March 27, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank PR Newswire SAN JOSE, Calif. , March 13, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders PR Newswire SAN JOSE, Calif. , March 2, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ca...

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology PR Newswire SAN JOSE, Calif. , Feb. 27, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the ...

Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board PR Newswire Board of leading experts in breast cancer to support development of clinical plans SAN JOSE, Calif. , Feb. 21, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NAS...

Anixa Biosciences to Present at Biotech Showcase 2023 PR Newswire SAN JOSE, Calif. , Dec. 19, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: Shifting Gears

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine PR Newswire SAN JOSE, Calif. , Dec. 8, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium PR Newswire SAN JOSE, Calif. , Nov. 8, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused...